Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4AC3

S.pneumoniae GlmU in complex with an antibacterial inhibitor

Summary for 4AC3
Entry DOI10.2210/pdb4ac3/pdb
Related4AA7 4AAW
DescriptorBIFUNCTIONAL PROTEIN GLMU, N-{2,4-DIMETHOXY-5-[(2-PIPERIDIN-1-YLBENZYL)sulfamoyl]phenyl}acetamide, SULFATE ION, ... (4 entities in total)
Functional Keywordstransferase, acetyl transferase, transferase-inhibitor complex
Biological sourceSTREPTOCOCCUS PNEUMONIAE
Cellular locationCytoplasm : Q8DQ18
Total number of polymer chains1
Total formula weight50025.08
Authors
Otterbein, L.,Breed, J.,Ogg, D.J. (deposition date: 2011-12-12, release date: 2012-02-15, Last modification date: 2023-12-20)
Primary citationGreen, O.M.,McKenzie, A.R.,Shapiro, A.B.,Otterbein, L.,Ni, H.,Patten, A.,Stokes, S.,Albert, R.,Kawatkar, S.,Breed, J.
Inhibitors of Acetyltransferase Domain of N-Acetylglucosamine-1-Phosphate-Uridyltransferase/ Glucosamine-1-Phosphate-Acetyltransferase (Glmu). Part 1: Hit to Lead Evaluation of a Novel Arylsulfonamide Series.
Bioorg.Med.Chem.Lett., 22:1510-, 2012
Cited by
PubMed Abstract: A novel arylsulfonamide-containing series of compounds represented by 1, discovered by highthroughput screening, inhibit the acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). X-ray structure determination confirmed that inhibitor binds at the site occupied by acetyl-CoA, indicating that series is competitive with this substrate. This letter documents our early hit-to-lead evaluation of the chemical series and some of the findings that led to improvement in in-vitro potency against Gram-negative and Gram-positive bacterial isozymes, exemplified by compound 40.
PubMed: 22297115
DOI: 10.1016/J.BMCL.2012.01.016
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

226707

건을2024-10-30부터공개중

PDB statisticsPDBj update infoContact PDBjnumon